Lebrikizumab Treatment in Adults with AsthmaJonathan Corren, John G. Matthews, Robert F. Lemanske et al.|New England Journal of Medicine|2011Cited by 1.5k
Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard TherapyNicola A. Hanania, William W. Busse, Oral Alpan et al.|Annals of Internal Medicine|2011Cited by 550
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trialsNicola A. Hanania, John G. Matthews, Phillip E. Korenblat et al.|The Lancet Respiratory Medicine|2016Cited by 465
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil CountsSurya P. Bhatt, Raolat M. Abdulai, Klaus F. Rabe et al.|New England Journal of Medicine|2023Cited by 452
Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary DiseaseMark T. Dransfield, Barry J. Make, Jeffrey L. Curtis et al.|American Journal of Respiratory and Critical Care Medicine|2016Cited by 358